Cargando…

P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS

Detalles Bibliográficos
Autores principales: Harrington, P., Saunders, J., Saha, C., Sheikh, A., Dillon, R., Raj, K., Cadman-Davies, L., Lechmere, T., Khan, H., Woodley, C., Asirvatham, S., Curto-Garcia, N., O’Sullivan, J., Kordasti, S., Radia, D., McLornan, D., Malim, M., Doores, K., Harrison, C., de Lavallade, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430025/
http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d
_version_ 1784779630996094976
author Harrington, P.
Saunders, J.
Saha, C.
Sheikh, A.
Dillon, R.
Raj, K.
Cadman-Davies, L.
Lechmere, T.
Khan, H.
Woodley, C.
Asirvatham, S.
Curto-Garcia, N.
O’Sullivan, J.
Kordasti, S.
Radia, D.
McLornan, D.
Malim, M.
Doores, K.
Harrison, C.
de Lavallade, H.
author_facet Harrington, P.
Saunders, J.
Saha, C.
Sheikh, A.
Dillon, R.
Raj, K.
Cadman-Davies, L.
Lechmere, T.
Khan, H.
Woodley, C.
Asirvatham, S.
Curto-Garcia, N.
O’Sullivan, J.
Kordasti, S.
Radia, D.
McLornan, D.
Malim, M.
Doores, K.
Harrison, C.
de Lavallade, H.
author_sort Harrington, P.
collection PubMed
description
format Online
Article
Text
id pubmed-9430025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94300252022-08-31 P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS Harrington, P. Saunders, J. Saha, C. Sheikh, A. Dillon, R. Raj, K. Cadman-Davies, L. Lechmere, T. Khan, H. Woodley, C. Asirvatham, S. Curto-Garcia, N. O’Sullivan, J. Kordasti, S. Radia, D. McLornan, D. Malim, M. Doores, K. Harrison, C. de Lavallade, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430025/ http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Harrington, P.
Saunders, J.
Saha, C.
Sheikh, A.
Dillon, R.
Raj, K.
Cadman-Davies, L.
Lechmere, T.
Khan, H.
Woodley, C.
Asirvatham, S.
Curto-Garcia, N.
O’Sullivan, J.
Kordasti, S.
Radia, D.
McLornan, D.
Malim, M.
Doores, K.
Harrison, C.
de Lavallade, H.
P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title_full P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title_fullStr P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title_full_unstemmed P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title_short P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
title_sort p990: t cell response and omicron variant neutralisation following vaccination against sars-cov-2 in patients with chronic myeloid disorders
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430025/
http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d
work_keys_str_mv AT harringtonp p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT saundersj p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT sahac p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT sheikha p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT dillonr p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT rajk p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT cadmandaviesl p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT lechmeret p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT khanh p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT woodleyc p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT asirvathams p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT curtogarcian p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT osullivanj p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT kordastis p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT radiad p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT mclornand p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT malimm p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT dooresk p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT harrisonc p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders
AT delavalladeh p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders